MXPA02001370A - 4-amino-1-aril-1,5-dihidro-pirrol-2-ona con propiedades anticonvulsivas y ansioliticas y metodo para la produccion de la misma. - Google Patents

4-amino-1-aril-1,5-dihidro-pirrol-2-ona con propiedades anticonvulsivas y ansioliticas y metodo para la produccion de la misma.

Info

Publication number
MXPA02001370A
MXPA02001370A MXPA02001370A MXPA02001370A MXPA02001370A MX PA02001370 A MXPA02001370 A MX PA02001370A MX PA02001370 A MXPA02001370 A MX PA02001370A MX PA02001370 A MXPA02001370 A MX PA02001370A MX PA02001370 A MXPA02001370 A MX PA02001370A
Authority
MX
Mexico
Prior art keywords
producing
anticonvulsive
same
anxiolytic properties
compounds
Prior art date
Application number
MXPA02001370A
Other languages
English (en)
Inventor
Bartsch Reni
Original Assignee
Dresden Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dresden Arzneimittel filed Critical Dresden Arzneimittel
Publication of MXPA02001370A publication Critical patent/MXPA02001370A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La invencion se relaciona con 1, 5-dihidropirrol-2-onas de formula general 1 las cuales contienen un radical arilo en la posicion 1 y un radical amina secundaria en la posicion 4, con procesos para su preparacion y con su uso como medicamentos, en particular para el tratamiento de epilepsias de diversas formas y para el tratamiento de estado de ansiedad y tension.
MXPA02001370A 1999-09-16 2000-09-02 4-amino-1-aril-1,5-dihidro-pirrol-2-ona con propiedades anticonvulsivas y ansioliticas y metodo para la produccion de la misma. MXPA02001370A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19944332A DE19944332A1 (de) 1999-09-16 1999-09-16 Antikonvulsiv und anxiolytisch wirkende 4-Amino-1-aryl-1,5-dihydro-pyrrol-2-one und Verfahren zu deren Herstellung
PCT/EP2000/008572 WO2001019793A1 (de) 1999-09-16 2000-09-02 Antikonvulsiv und anxiolytisch wirkende 4-amino-1-aryl-1,5-dihydro-pyrrol-2-one und verfahren zu deren darstellung

Publications (1)

Publication Number Publication Date
MXPA02001370A true MXPA02001370A (es) 2004-09-10

Family

ID=7922190

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02001370A MXPA02001370A (es) 1999-09-16 2000-09-02 4-amino-1-aril-1,5-dihidro-pirrol-2-ona con propiedades anticonvulsivas y ansioliticas y metodo para la produccion de la misma.

Country Status (20)

Country Link
US (1) US6500821B1 (es)
EP (1) EP1212297A1 (es)
JP (1) JP2003509407A (es)
KR (1) KR20020027657A (es)
CN (1) CN1374948A (es)
AR (1) AR025700A1 (es)
AU (1) AU7283000A (es)
BG (1) BG106437A (es)
BR (1) BR0013961A (es)
CA (1) CA2317257A1 (es)
CZ (1) CZ2002915A3 (es)
DE (1) DE19944332A1 (es)
EE (1) EE200200137A (es)
HU (1) HUP0202607A3 (es)
IL (1) IL147808A0 (es)
MX (1) MXPA02001370A (es)
NO (1) NO20021143L (es)
SK (1) SK3782002A3 (es)
TR (1) TR200200678T2 (es)
WO (1) WO2001019793A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106008304B (zh) * 2016-05-18 2018-07-17 湖北科技学院 一种1,3-二氢吡咯-2-酮类化合物及其合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH543504A (de) * 1971-03-25 1973-10-31 Lonza Ag Verfahren zur Herstellung 1-substituierter 4-Aminopyrrolin-3-one-(2)
GB8310266D0 (en) 1982-05-12 1983-05-18 Ici America Inc Pyrazolopyridine compounds

Also Published As

Publication number Publication date
CZ2002915A3 (cs) 2002-06-12
EE200200137A (et) 2003-04-15
BG106437A (bg) 2002-09-30
AU7283000A (en) 2001-04-17
US6500821B1 (en) 2002-12-31
NO20021143D0 (no) 2002-03-07
TR200200678T2 (tr) 2002-07-22
SK3782002A3 (en) 2002-07-02
EP1212297A1 (de) 2002-06-12
AR025700A1 (es) 2002-12-11
DE19944332A1 (de) 2001-03-22
KR20020027657A (ko) 2002-04-13
NO20021143L (no) 2002-03-07
CA2317257A1 (en) 2001-03-16
IL147808A0 (en) 2002-08-14
BR0013961A (pt) 2002-05-21
HUP0202607A3 (en) 2003-05-28
JP2003509407A (ja) 2003-03-11
CN1374948A (zh) 2002-10-16
WO2001019793A1 (de) 2001-03-22
HUP0202607A2 (hu) 2002-12-28

Similar Documents

Publication Publication Date Title
MXPA02008056A (es) Derivados de 2-oxo-1 pirrolidina, proceso para prepararlos y sus aplicaciones.
YU29503A (sh) Novi antiholinergici koji se mogu primeniti kao lekovi, kao i postupak za njihovo dobijanje
GEP20022676B (en) 4-Phenyl-Pyridine Derivatives, Method for Their Production and Their Use for Treatment of Disorders Caused by Antagonist of NK-1 Receptors
MX9605128A (es) Nuevos derivados de aminoacidos, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos.
MXPA04005456A (es) Derivados de acetileno que tienen actividad antagonistica de mglur5.
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
DK0616807T3 (da) Benzimidazol anvendelig i behandlingen af forstyrrelser i centralnervesystemet
ZA9410339B (en) Diazabicyclic neurokinin antagonists
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
BG106586A (en) Pyrazolopyramidines as therapeutic agents
MX9709240A (es) Fenilpiridazinonas.
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
ATE356797T1 (de) Azidfreies verfahren zur herstellung von 1,2- diaminoverbindungen
NO972726D0 (no) Tricykliske forbindelser
UA49884C2 (uk) ПОХІДНІ <font face="Symbol">a</font>-ГІДРОКСИКАРБОНОВОЇ КИСЛОТИ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
HK1056725A1 (en) 2-Thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry.
WO2004033423A3 (en) Anticancer compounds
ZA200604654B (en) Pyrazolopyrimidines
WO2001090102A3 (de) 6-heterocyclyl-3-oxo-3,4-dihydro-chinoxaline
MX9701569A (es) Pirimidin(tio)onas substituidas.
MXPA02001370A (es) 4-amino-1-aril-1,5-dihidro-pirrol-2-ona con propiedades anticonvulsivas y ansioliticas y metodo para la produccion de la misma.
MY130488A (en) Process for preparing 3,3',6,6'-tetraalkyl-2,2'-biphenols and 3,3',6,6'-tetraalkyl-5,5'-dihalo-2,2'-biphenols
WO2003028652A3 (en) Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis
PT1049672E (pt) Derivados de azetidinocarboxamida para o tratamento de disturbios do snc
WO2001010849A3 (de) Substituierte arylalkylamino-1,3,5-triazine als herbizide